Relief of Extracellular Matrix Deposition Repression by Downregulation of IRF1-Mediated TWEAK/Fn14 Signaling in Keloids

J Invest Dermatol. 2023 Jul;143(7):1208-1219.e6. doi: 10.1016/j.jid.2023.01.008. Epub 2023 Jan 28.

Abstract

Keloids represent a fibrotic disorder characterized by the excessive deposition of extracellular matrix (ECM). However, the mechanisms through which ECM deposition in keloids is regulated remain elusive. In this study, we found that the expression of both TWEAK and its cognate receptor Fn14 was significantly downregulated in keloids and that TWEAK/Fn14 signaling repressed the expression of ECM-related genes in keloid fibroblasts. The IRF1 gene was essential for this repression, and the TWEAK/Fn14 downstream transcription factor p65 directly bound to the promoter of the IRF1 gene and induced its expression. Furthermore, in patients with keloid, the expression of TWEAK and Fn14 was negatively correlated with that of ECM genes and positively correlated with that of IRF1. These observations indicate that relief of TWEAK/Fn14/IRF1-mediated ECM deposition repression contributes to keloid pathogenesis, and the identified mechanism and related molecules provide potential targets for keloid treatment in the future.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytokine TWEAK / genetics
  • Down-Regulation
  • Extracellular Matrix / metabolism
  • Humans
  • Interferon Regulatory Factor-1 / genetics
  • Interferon Regulatory Factor-1 / metabolism
  • Keloid* / genetics
  • Signal Transduction
  • TWEAK Receptor / genetics
  • TWEAK Receptor / metabolism
  • Tumor Necrosis Factors / genetics
  • Tumor Necrosis Factors / metabolism

Substances

  • TWEAK Receptor
  • Cytokine TWEAK
  • Tumor Necrosis Factors
  • IRF1 protein, human
  • Interferon Regulatory Factor-1